LEP and obesity due to melanocortin 4 receptor deficiency: This combination of effects, enhanced insulin signaling, normalization of leptin activity, and a macrophage shift toward the M2 phenotype, suggests that anthocyanidins hold considerable therapeutic potential for mitigating chronic inflammation associated with obesity and insulin resistance (Figure 1).